DNA methylation of NKX6-2 has been reported to be associated with aggressive RCC as part of a methylation signature for the detection of bladder cancer and to be a target of hypermethylation in other tumor entities [33,34,35,36]. This evidence concerns the gene NKX6-2 and urinary bladder cancer.